Novavax (NASDAQ:NVAX) Target Raised by B. Riley to $106.00

0
43

Novavax stock has undergone multiple analysts rating changes in the recent past.  Novavax stock Target Raised by   B. Riley on 6/29/2020. In a note to investors, the firm issued a new target price of $106.00. The analysts previously had $74.00 target price. B. Riley’s price target would indicate a potential upside of 36.97% from the stock’s previous close.

Shares of Novavax traded up $9.74 on Monday, reaching $87.13. 3383033 shares of the stock traded hands, compared to its average volume of 9197061. Shares of were trading at $87.13 on Monday. The firm’s 50 day moving average is $$41.25 and its 200 day moving average is $15.63.Novavax  has a 12 month low of $78.70 and a 12 month high of $88.00. While on yearly highs and lows, Novavax today has traded high as $88.00 and has touched $78.70 on the downward trend.

Novavax Earnings and What to expect: 

Novavax last released its earnings data on May 11th, 2020. The biopharmaceutical company reported ($0.58) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.67) by $0.09. The business had revenue of $3.38 million for the quarter, compared to analysts’ expectations of $3.50 million. Novavax has generated ($5.80) earnings per share over the last year. Novavax has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, August 5th, 2020 based off prior year’s report dates.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 1.60%
  • On 6/18/2020 Insider Gregory M Glenn Sell 16,749 at average share price of $59.53 which equates to $997,067.97 in money value.
  • On 6/3/2020 Director James F Young Buy 1,500 at average price of  $48.83 with total value of : Not Data Available
  • On 1/31/2020 Insider Gregory M. Glenn Buy 1,250 at average price of  $3.86 with total value of : $4,825.00
  • See More Analyst Rating at: RATING

Other Analyst’s rating for Novavax

  • 6/29/2020 – Novavax had its price target raised by analysts at HC Wainwright from $50.00 to $101.00. They now have a “buy” rating on the stock.
  • 6/19/2020 – Novavax had its price target raised by analysts at Cantor Fitzgerald from $45.00 to $88.00. They now have an “overweight” rating on the stock.
  • 6/18/2020 – Novavax was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $58.00 price target on the stock.
  • 6/5/2020 – Novavax had its price target raised by analysts at B. Riley from $61.00 to $74.00.
  • See More Analyst Rating at: RATING

Other rating updates by B. Riley: 

  • 6/26/2020 – Cinemark had its “hold” rating re-affirmed by analysts at B. Riley. They now have a $16.00 price target on the stock.
  • 6/26/2020 – Marcus had its “hold” rating re-affirmed by analysts at B. Riley. They now have a $15.00 price target on the stock.
  • 6/29/2020 – DURECT had its “buy” rating re-affirmed by analysts at B. Riley. They now have a $5.00 price target on the stock.
  • 6/26/2020 – Nanometrics had its “buy” rating re-affirmed by analysts at B. Riley. They now have a $46.00 price target on the stock.
  • See More Analyst Rating at: RATING

Novavax (NASDAQ:NVAX) Moving Average Technical Analysis

5 day Moving Average is $$74.81 And 5 day price change is $12.64 (19.52%)  with average volume for 5 day average is 9,959,100. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $56.00 and 20 day price change is $31.35 (68.09%) and average 20 day moving volume is 7,773,345. 50 day moving average is $41.25  and 50 day price change is $59.29 ( 327.57%)  and with average volume for 50 days is : 10,287,336. 200 day moving average is $15.63  and 200 day price change is $71.65 (#ERROR!)  and with average volume for 200 days is : 5,821,675.

See More Analyst Rating at: RATING